Serveur d'exploration Tocilizumab - Checkpoint (PubMed)

Index « MedMesh.i » - entrée « Prospective Studies »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Proprotein Convertase 9 < Prospective Studies < Prostaglandins  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 102.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000222 (2020) Seong-Kyu Kim ; Sang Gyu Kwak [Corée du Sud] ; Jung-Yoon ChoeAssociation between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: Results from prospective nationwide KOBIO Registry.
000260 (2019) Nienke M. Ter Haar [Pays-Bas] ; E H Pieter Van Dijkhuizen [Pays-Bas] ; Joost F. Swart [Pays-Bas] ; Annet Van Royen-Kerkhof [Pays-Bas] ; Ayman El Idrissi [Pays-Bas] ; Arjen P. Leek [Pays-Bas] ; Wilco De Jager [Pays-Bas] ; Mark C H. De Groot [Pays-Bas] ; Saskia Haitjema [Pays-Bas] ; Dirk Holzinger [Allemagne] ; Dirk Foell [Allemagne] ; Jorg Van Loosdregt [Pays-Bas] ; Nico M. Wulffraat [Pays-Bas] ; Sytze De Roock [Pays-Bas] ; Sebastiaan J. Vastert [Pays-Bas]Treatment to Target Using Recombinant Interleukin-1 Receptor Antagonist as First-Line Monotherapy in New-Onset Systemic Juvenile Idiopathic Arthritis: Results From a Five-Year Follow-Up Study.
000275 (2019) Kentaro Chino [Japon] ; Tsuneo Kondo [Japon] ; Ryota Sakai [Japon] ; Shuntaro Saito [Japon] ; Yusuke Okada [Japon] ; Akiko Shibata [Japon] ; Takahiko Kurasawa [Japon] ; Ayumi Okuyama [Japon] ; Hirofumi Takei [Japon] ; Koichi Amano [Japon]Tocilizumab monotherapy for polymyalgia rheumatica: A prospective, single-center, open-label study.
000308 (2019) Li Zhou [République populaire de Chine] ; Dong-Mei Xiao [République populaire de Chine] ; Wen Qin [République populaire de Chine] ; Bin-Hua Xie [République populaire de Chine] ; Ting-Hui Wang [République populaire de Chine] ; Hua Huang [République populaire de Chine] ; Bao-Jing Zhao [République populaire de Chine] ; Xi Han [République populaire de Chine] ; Qing-Qing Sun [République populaire de Chine] ; Xiu-Di Wu [République populaire de Chine] ; Han Cen [République populaire de Chine]The clinical value of hematological markers in rheumatoid arthritis patients treated with tocilizumab.
000366 (2019) Carlotta Nannini [Italie] ; Laura Niccoli [Italie] ; Stelvio Sestini [Italie] ; Iashar Laghai [Italie] ; Angela Coppola [Italie] ; Fabrizio Cantini [Oman]Remission maintenance after tocilizumab dose-tapering and interruption in patients with giant cell arteritis: an open-label, 18-month, prospective, pilot study.
000483 (2019) Samah Hamdy Elmedany [Égypte] ; Aly Elsayed Mohamed [Égypte] ; Sahar Mahfouz Abdel Galil [Égypte]Efficacy and safety profile of intravenous tocilizumab versus intravenous abatacept in treating female Saudi Arabian patients with active moderate-to-severe rheumatoid arthritis.
000505 (2019) Kim Lauper [Suisse] ; Denis Mongin [Suisse] ; Deshire Alpizar-Rodriguez [Suisse] ; Catalin Codreanu [Italie] ; Florenzo Iannone [Italie] ; Eirik K. Kristianslund [Norvège] ; Tore K. Kvien [Norvège] ; Karel Pavelka [République tchèque] ; Manuel Pombo-Suarez [Espagne] ; Maria J. Santos ; Cem Gabay [Suisse] ; Axel Finckh [Suisse] ; Delphine S. Courvoisier [Suisse]Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution.
000515 (2019) Anna Leszczynska [Espagne] ; Blanca Molins [Espagne] ; Estrella Fernández [Espagne] ; Alfredo Adán [Espagne] ; Santiago Ortiz-Perez [Espagne]Cytokine production in thyroid eye disease: in vitro effects of dexamethasone and IL-6 blockade with tocilizumab.
000517 (2019) Priyankar Pal [Inde] ; Prabhas Prasun Giri [Inde] ; Rajiv Sinha [Inde]Cyclosporine in Resistant Systemic Arthritis - A Cheaper Alternative to Biologics.
000525 (2019) Héctor Corominas ; Cayetano Alegre ; Javier Narváez [Espagne] ; Carlos Marras Fernández-Cid ; Vicenç Torrente-Segarra ; Manuel Rodríguez G Mez ; Francisco Maceiras Pan ; Rosa María Morlà ; Fernando José Rodríguez Martínez ; Antoni G Mez-Centeno [Espagne] ; Laura Losada Ares ; Rocío González Molina ; Silvia Paredes González-Albo ; Joan Dalmau-Carolà ; Carolina Pérez-García [Espagne] ; Ceferino Barbazán Álvarez ; Liliana Ercole [Espagne] ; Maria Ngeles Terrancle [Espagne]Correlation of fatigue with other disease related and psychosocial factors in patients with rheumatoid arthritis treated with tocilizumab: ACT-AXIS study.
000528 (2019) Yi-Ming Chen [Taïwan] ; Wen-Nan Huang [Taïwan] ; Tsai-Ling Liao [Taïwan] ; Jun-Pen Chen [Taïwan] ; Sheng-Shun Yang [Taïwan] ; Hsin-Hua Chen [Taïwan] ; Tsu-Yi Hsieh [Taïwan] ; Wei-Ting Hung [Taïwan] ; Yi-Hsing Chen [Taïwan] ; Der-Yuan Chen [Taïwan]Comparisons of hepatitis C viral replication in patients with rheumatoid arthritis receiving tocilizumab, abatacept and tofacitinib therapy.
000529 (2019) Stephanie Finzel [Allemagne] ; Sebastian Kraus [Allemagne] ; Camille Pinto Figueiredo [Allemagne] ; Adrian Regensburger [Allemagne] ; Roland Kocijan [Allemagne] ; Juergen Rech [Allemagne] ; Georg Schett [Allemagne]Comparison of the effects of tocilizumab monotherapy and adalimumab in combination with methotrexate on bone erosion repair in rheumatoid arthritis.
000533 (2019) Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Elodie Perrodeau [France] ; Thomas Bardin [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; Rene-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Arnaud Constantin [France] ; Philippe Ravaud [France] ; Xavier Mariette [France]Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study.
000617 (2018) Anaïs Huwart [France] ; Florent Garrigues [France] ; Sandrine Jousse-Joulin [France] ; Thierry Marhadour [France] ; Dewi Guellec [France] ; Divi Cornec [France] ; Maelenn Gouillou [France] ; Alain Saraux [France] ; Valérie Devauchelle-Pensec [France]Ultrasonography and magnetic resonance imaging changes in patients with polymyalgia rheumatica treated by tocilizumab.
000621 (2018) Xiufang Kong [République populaire de Chine] ; Xiaojie Zhang [République populaire de Chine] ; Peng Lv [République populaire de Chine] ; Xiaomeng Cui [République populaire de Chine] ; Lili Ma [République populaire de Chine] ; Huiyong Chen [République populaire de Chine] ; Hao Liu [République populaire de Chine] ; Jiang Lin [République populaire de Chine] ; Lindi Jiang [République populaire de Chine]Treatment of Takayasu arteritis with the IL-6R antibody tocilizumab vs. cyclophosphamide.
000652 (2018) Yuko Kaneko [Japon] ; Masaru Kato [Japon] ; Yoshiya Tanaka [Japon] ; Masayuki Inoo [Japon] ; Hitomi Kobayashi-Haraoka [Japon] ; Koichi Amano [Japon] ; Masayuki Miyata [Japon] ; Yohko Murakawa [Japon] ; Hidekara Yasuoka [Japon] ; Shintaro Hirata [Japon] ; Eiichi Tanaka [Japon] ; Nobuyuki Miyasaka [Japon] ; Hisashi Yamanaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Tsutomu Takeuchi [Japon]Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study).
000655 (2018) Maxime Samson [France] ; Hervé Devilliers [France] ; Kim Heang Ly [France] ; François Maurier [France] ; Boris Bienvenu [France] ; Benjamin Terrier [France] ; Pierre Charles [France] ; Loïc Guillevin [France] ; Jean-François Besancenot [France] ; Eric Liozon [France] ; Anne Laure Fauchais [France] ; Romaric Loffroy [France] ; Christine Binquet [France] ; Sylvain Audia [France] ; Raphaèle Seror [France] ; Xavier Mariette [France] ; Bernard Bonnotte [France]Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study.
000656 (2018) Hanna Lythgoe [Royaume-Uni] ; Eileen Baildam [Royaume-Uni] ; Michael W. Beresford [Royaume-Uni] ; Gavin Cleary [Royaume-Uni] ; Liza J. Mccann [Royaume-Uni] ; Clare E. Pain [Royaume-Uni]Tocilizumab as a potential therapeutic option for children with severe, refractory juvenile localized scleroderma.
000718 (2018) L. De-Pablo-G Mez-De-Lia O [Espagne] ; J I Fernández-Vigo [Espagne] ; J. Troyano-Rivas [Espagne] ; C. Ni O-Rueda [Espagne] ; Á Romo-L Pez [Espagne] ; R. G Mez-De-Lia O [Espagne]Response to tocilizumab treatment in Graves' ophthalmopathy by measuring rectus muscle thickness and chemosis using optical coherence tomography.
000773 (2018) Alexander G S. Oldroyd [Royaume-Uni] ; Deborah P M. Symmons [Royaume-Uni] ; Jamie C. Sergeant [Royaume-Uni] ; Lianne Kearsley-Fleet [Royaume-Uni] ; Kath Watson [Royaume-Uni] ; Mark Lunt [Royaume-Uni] ; Kimme L. Hyrich [Royaume-Uni]Long-term persistence with rituximab in patients with rheumatoid arthritis.
000800 (2018) William Terreaux [France] ; Claire Masson [France] ; Jean-Paul Eschard [France] ; Thomas Bardin [France] ; Arnaud Constantin [France] ; Loïc Le Dantec [France] ; Christian Marcelli [France] ; Aleth Perdriger [France] ; Claire Scotto Di Fazano [France] ; Daniel Wendling [France] ; Jean Sibilia [France] ; Jacques Morel [France] ; Jean-Hugues Salmon [France]Incidence of paradoxical reactions in patients treated with tocilizumab for rheumatoid arthritis: Data from the French registry REGATE.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Prospective Studies" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i  \
                -Sk "Prospective Studies" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Prospective Studies
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021